Double your impact Match My Donation
Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.
By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer. Immunotherapy is already saving lives, and while responses vary from patient to patient, with further research, we can bring more effective treatments to more cancer patients.
See how immunotherapy works
See Where Your Money Goes
Fundraise for immunotherapy
Share Stories and Connect
Become a corporate sponsor
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an impressive total of $110,000.